New Policies on Marijuana's Status.:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Science Publishers, Inc.,
2023.
|
| Schriftenreihe: | Government procedures and operations.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 116th Congress, 1st Session, H. R. 1151 |
| Beschreibung: | 1 online resource (342 p.). |
| ISBN: | 9798891130777 |
Internformat
MARC
| LEADER | 00000cam a22000007i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1395182714 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 230909s2023 nyu o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |e rda |c EBLCP |d OCLCO |d OCLCQ |d YDX |d OCLCO |d UKAHL |d OCLCF |d OCLCO |d N$T | ||
| 020 | |a 9798891130777 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1395182714 | ||
| 050 | 4 | |a HV5822.M3 |b L44 2023 | |
| 082 | 7 | |a 362.295 |2 23/eng/20231127 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Lee, Jack M. | |
| 245 | 1 | 0 | |a New Policies on Marijuana's Status. |
| 264 | 1 | |a New York : |b Nova Science Publishers, Inc., |c 2023. | |
| 300 | |a 1 online resource (342 p.). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Government Procedures and Operations | |
| 505 | 0 | |a Intro -- Contents -- Preface -- Chapter 1 -- Cannabis Policies for the New Decade0F* -- Opening Statement of Hon. Anna G. Eshoo, a Representative in Congress from the State of California -- Prepared Statement of Hon. Anna G. Eshoo -- Opening Statement of Hon. Michael C. Burgess, a Representative in Congress from the State of Texas -- Prepared Statement of Hon. Michael C. Burgess -- Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey -- Prepared Statement of Hon. Frank Pallone, Jr. | |
| 505 | 8 | |a Opening Statement of Hon. Greg Walden, a Representative in Congress from the State of Oregon -- Prepared Statement of Hon. Greg Walden -- Statement of Nora D. Volkow, M.D. Director, National Institute on Drug Abuse, National Institutes of Health -- Prepared Statement of Nora Volkow, M.D. -- Background -- Adverse Health Effect of Cannabis -- Prenatal and Adolescent Development -- Cannabis Use Disorder -- Mental Illness -- Lung Injuries -- Other Medical Complications -- Impaired Driving -- Therapeutic Potential of Cannabis and Its Constituent Cannabinoids | |
| 505 | 8 | |a Research Supported by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) -- Conducting Research with Schedule I Substances -- Obtaining and Modifying a Registration to Conduct Research with Cannabis and Other Schedule I Drugs is Challenging -- NIDA Is the Only Source of Cannabis in the United States Permitted for Research -- Researchers Are Unable to Access Marketed Cannabis Products -- Statement of Douglas C. Throckmorton, M.D. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration | |
| 505 | 8 | |a Prepared Statement of Douglas C. Throckmorton -- Introduction -- Statement of Matthew J. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration -- Prepared Statement of the U.S. Department of Justice, Matthew J. Strait -- The Controlled Substances Act and Marijuana -- Current Statutory Framework Governing the Registration of Certain Individuals Handling Marijuana under the CSA -- DEA's August 2016 Policy Statement and Subsequent Efforts to Expand the Number of Registrants to Grow Marijuana -- Conclusion -- Prepared Statement of Hon. Eliot L. Engel | |
| 505 | 8 | |a 116th Congress, 1st Session, H.R. 171 -- A BILL -- Section 1. Short Title -- Sec. 2. Scheduling of Marijuana -- Prescriptions -- Sec. 3. Definitions -- Sec. 4. Relation of Act to Certain Prohibitions Relating to Smoking -- 116th Congress, 1st Session, H. R. 601 -- A BILL -- Section 1. Short Title -- Sec. 2. Increasing the Number of Federally Registered Manufacturers of Cannabis for Legitimate Research Purposes -- Sec. 3. Provision by Department of Veterans Affairs Health Care Providers of Information Regarding Veteran Participation in Federally Approved Cannabis Clinical Trials | |
| 500 | |a 116th Congress, 1st Session, H. R. 1151 | ||
| 650 | 0 | |a Marijuana |x Government policy |z United States. | |
| 650 | 6 | |a Marijuana |x Politique gouvernementale |z États-Unis. | |
| 650 | 7 | |a Marijuana |x Government policy |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 776 | 0 | 8 | |i Print version: |a Lee, Jack M. |t New Policies on Marijuana's Status |d New York : Nova Science Publishers, Incorporated,c2023 |z 9798886978704 |
| 830 | 0 | |a Government procedures and operations. |0 http://id.loc.gov/authorities/names/no2012008976 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3641863 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH41689847 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL30621234 | ||
| 938 | |a EBSCOhost |b EBSC |n 3641863 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1395182714 |
|---|---|
| _version_ | 1816882571198332930 |
| adam_text | |
| any_adam_object | |
| author | Lee, Jack M. |
| author_facet | Lee, Jack M. |
| author_role | |
| author_sort | Lee, Jack M. |
| author_variant | j m l jm jml |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | H - Social Science |
| callnumber-label | HV5822 |
| callnumber-raw | HV5822.M3 L44 2023 |
| callnumber-search | HV5822.M3 L44 2023 |
| callnumber-sort | HV 45822 M3 L44 42023 |
| callnumber-subject | HV - Social Pathology, Criminology |
| collection | ZDB-4-EBA |
| contents | Intro -- Contents -- Preface -- Chapter 1 -- Cannabis Policies for the New Decade0F* -- Opening Statement of Hon. Anna G. Eshoo, a Representative in Congress from the State of California -- Prepared Statement of Hon. Anna G. Eshoo -- Opening Statement of Hon. Michael C. Burgess, a Representative in Congress from the State of Texas -- Prepared Statement of Hon. Michael C. Burgess -- Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey -- Prepared Statement of Hon. Frank Pallone, Jr. Opening Statement of Hon. Greg Walden, a Representative in Congress from the State of Oregon -- Prepared Statement of Hon. Greg Walden -- Statement of Nora D. Volkow, M.D. Director, National Institute on Drug Abuse, National Institutes of Health -- Prepared Statement of Nora Volkow, M.D. -- Background -- Adverse Health Effect of Cannabis -- Prenatal and Adolescent Development -- Cannabis Use Disorder -- Mental Illness -- Lung Injuries -- Other Medical Complications -- Impaired Driving -- Therapeutic Potential of Cannabis and Its Constituent Cannabinoids Research Supported by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) -- Conducting Research with Schedule I Substances -- Obtaining and Modifying a Registration to Conduct Research with Cannabis and Other Schedule I Drugs is Challenging -- NIDA Is the Only Source of Cannabis in the United States Permitted for Research -- Researchers Are Unable to Access Marketed Cannabis Products -- Statement of Douglas C. Throckmorton, M.D. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration Prepared Statement of Douglas C. Throckmorton -- Introduction -- Statement of Matthew J. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration -- Prepared Statement of the U.S. Department of Justice, Matthew J. Strait -- The Controlled Substances Act and Marijuana -- Current Statutory Framework Governing the Registration of Certain Individuals Handling Marijuana under the CSA -- DEA's August 2016 Policy Statement and Subsequent Efforts to Expand the Number of Registrants to Grow Marijuana -- Conclusion -- Prepared Statement of Hon. Eliot L. Engel 116th Congress, 1st Session, H.R. 171 -- A BILL -- Section 1. Short Title -- Sec. 2. Scheduling of Marijuana -- Prescriptions -- Sec. 3. Definitions -- Sec. 4. Relation of Act to Certain Prohibitions Relating to Smoking -- 116th Congress, 1st Session, H. R. 601 -- A BILL -- Section 1. Short Title -- Sec. 2. Increasing the Number of Federally Registered Manufacturers of Cannabis for Legitimate Research Purposes -- Sec. 3. Provision by Department of Veterans Affairs Health Care Providers of Information Regarding Veteran Participation in Federally Approved Cannabis Clinical Trials |
| ctrlnum | (OCoLC)1395182714 |
| dewey-full | 362.295 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.295 |
| dewey-search | 362.295 |
| dewey-sort | 3362.295 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04596cam a22004697i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1395182714</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">230909s2023 nyu o ||| 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">EBLCP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDX</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9798891130777</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1395182714</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HV5822.M3</subfield><subfield code="b">L44 2023</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.295</subfield><subfield code="2">23/eng/20231127</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lee, Jack M.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New Policies on Marijuana's Status.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Science Publishers, Inc.,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (342 p.).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Government Procedures and Operations</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Contents -- Preface -- Chapter 1 -- Cannabis Policies for the New Decade0F* -- Opening Statement of Hon. Anna G. Eshoo, a Representative in Congress from the State of California -- Prepared Statement of Hon. Anna G. Eshoo -- Opening Statement of Hon. Michael C. Burgess, a Representative in Congress from the State of Texas -- Prepared Statement of Hon. Michael C. Burgess -- Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey -- Prepared Statement of Hon. Frank Pallone, Jr.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Opening Statement of Hon. Greg Walden, a Representative in Congress from the State of Oregon -- Prepared Statement of Hon. Greg Walden -- Statement of Nora D. Volkow, M.D. Director, National Institute on Drug Abuse, National Institutes of Health -- Prepared Statement of Nora Volkow, M.D. -- Background -- Adverse Health Effect of Cannabis -- Prenatal and Adolescent Development -- Cannabis Use Disorder -- Mental Illness -- Lung Injuries -- Other Medical Complications -- Impaired Driving -- Therapeutic Potential of Cannabis and Its Constituent Cannabinoids</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Research Supported by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) -- Conducting Research with Schedule I Substances -- Obtaining and Modifying a Registration to Conduct Research with Cannabis and Other Schedule I Drugs is Challenging -- NIDA Is the Only Source of Cannabis in the United States Permitted for Research -- Researchers Are Unable to Access Marketed Cannabis Products -- Statement of Douglas C. Throckmorton, M.D. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Prepared Statement of Douglas C. Throckmorton -- Introduction -- Statement of Matthew J. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration -- Prepared Statement of the U.S. Department of Justice, Matthew J. Strait -- The Controlled Substances Act and Marijuana -- Current Statutory Framework Governing the Registration of Certain Individuals Handling Marijuana under the CSA -- DEA's August 2016 Policy Statement and Subsequent Efforts to Expand the Number of Registrants to Grow Marijuana -- Conclusion -- Prepared Statement of Hon. Eliot L. Engel</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">116th Congress, 1st Session, H.R. 171 -- A BILL -- Section 1. Short Title -- Sec. 2. Scheduling of Marijuana -- Prescriptions -- Sec. 3. Definitions -- Sec. 4. Relation of Act to Certain Prohibitions Relating to Smoking -- 116th Congress, 1st Session, H. R. 601 -- A BILL -- Section 1. Short Title -- Sec. 2. Increasing the Number of Federally Registered Manufacturers of Cannabis for Legitimate Research Purposes -- Sec. 3. Provision by Department of Veterans Affairs Health Care Providers of Information Regarding Veteran Participation in Federally Approved Cannabis Clinical Trials</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">116th Congress, 1st Session, H. R. 1151</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Marijuana</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Marijuana</subfield><subfield code="x">Politique gouvernementale</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Marijuana</subfield><subfield code="x">Government policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Lee, Jack M.</subfield><subfield code="t">New Policies on Marijuana's Status</subfield><subfield code="d">New York : Nova Science Publishers, Incorporated,c2023</subfield><subfield code="z">9798886978704</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Government procedures and operations.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2012008976</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3641863</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH41689847</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL30621234</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3641863</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States fast |
| geographic_facet | United States |
| id | ZDB-4-EBA-on1395182714 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:30:43Z |
| institution | BVB |
| isbn | 9798891130777 |
| language | English |
| oclc_num | 1395182714 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (342 p.). |
| psigel | ZDB-4-EBA |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Nova Science Publishers, Inc., |
| record_format | marc |
| series | Government procedures and operations. |
| series2 | Government Procedures and Operations |
| spelling | Lee, Jack M. New Policies on Marijuana's Status. New York : Nova Science Publishers, Inc., 2023. 1 online resource (342 p.). text txt rdacontent computer c rdamedia online resource cr rdacarrier Government Procedures and Operations Intro -- Contents -- Preface -- Chapter 1 -- Cannabis Policies for the New Decade0F* -- Opening Statement of Hon. Anna G. Eshoo, a Representative in Congress from the State of California -- Prepared Statement of Hon. Anna G. Eshoo -- Opening Statement of Hon. Michael C. Burgess, a Representative in Congress from the State of Texas -- Prepared Statement of Hon. Michael C. Burgess -- Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey -- Prepared Statement of Hon. Frank Pallone, Jr. Opening Statement of Hon. Greg Walden, a Representative in Congress from the State of Oregon -- Prepared Statement of Hon. Greg Walden -- Statement of Nora D. Volkow, M.D. Director, National Institute on Drug Abuse, National Institutes of Health -- Prepared Statement of Nora Volkow, M.D. -- Background -- Adverse Health Effect of Cannabis -- Prenatal and Adolescent Development -- Cannabis Use Disorder -- Mental Illness -- Lung Injuries -- Other Medical Complications -- Impaired Driving -- Therapeutic Potential of Cannabis and Its Constituent Cannabinoids Research Supported by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) -- Conducting Research with Schedule I Substances -- Obtaining and Modifying a Registration to Conduct Research with Cannabis and Other Schedule I Drugs is Challenging -- NIDA Is the Only Source of Cannabis in the United States Permitted for Research -- Researchers Are Unable to Access Marketed Cannabis Products -- Statement of Douglas C. Throckmorton, M.D. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration Prepared Statement of Douglas C. Throckmorton -- Introduction -- Statement of Matthew J. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration -- Prepared Statement of the U.S. Department of Justice, Matthew J. Strait -- The Controlled Substances Act and Marijuana -- Current Statutory Framework Governing the Registration of Certain Individuals Handling Marijuana under the CSA -- DEA's August 2016 Policy Statement and Subsequent Efforts to Expand the Number of Registrants to Grow Marijuana -- Conclusion -- Prepared Statement of Hon. Eliot L. Engel 116th Congress, 1st Session, H.R. 171 -- A BILL -- Section 1. Short Title -- Sec. 2. Scheduling of Marijuana -- Prescriptions -- Sec. 3. Definitions -- Sec. 4. Relation of Act to Certain Prohibitions Relating to Smoking -- 116th Congress, 1st Session, H. R. 601 -- A BILL -- Section 1. Short Title -- Sec. 2. Increasing the Number of Federally Registered Manufacturers of Cannabis for Legitimate Research Purposes -- Sec. 3. Provision by Department of Veterans Affairs Health Care Providers of Information Regarding Veteran Participation in Federally Approved Cannabis Clinical Trials 116th Congress, 1st Session, H. R. 1151 Marijuana Government policy United States. Marijuana Politique gouvernementale États-Unis. Marijuana Government policy fast United States fast Print version: Lee, Jack M. New Policies on Marijuana's Status New York : Nova Science Publishers, Incorporated,c2023 9798886978704 Government procedures and operations. http://id.loc.gov/authorities/names/no2012008976 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3641863 Volltext |
| spellingShingle | Lee, Jack M. New Policies on Marijuana's Status. Government procedures and operations. Intro -- Contents -- Preface -- Chapter 1 -- Cannabis Policies for the New Decade0F* -- Opening Statement of Hon. Anna G. Eshoo, a Representative in Congress from the State of California -- Prepared Statement of Hon. Anna G. Eshoo -- Opening Statement of Hon. Michael C. Burgess, a Representative in Congress from the State of Texas -- Prepared Statement of Hon. Michael C. Burgess -- Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey -- Prepared Statement of Hon. Frank Pallone, Jr. Opening Statement of Hon. Greg Walden, a Representative in Congress from the State of Oregon -- Prepared Statement of Hon. Greg Walden -- Statement of Nora D. Volkow, M.D. Director, National Institute on Drug Abuse, National Institutes of Health -- Prepared Statement of Nora Volkow, M.D. -- Background -- Adverse Health Effect of Cannabis -- Prenatal and Adolescent Development -- Cannabis Use Disorder -- Mental Illness -- Lung Injuries -- Other Medical Complications -- Impaired Driving -- Therapeutic Potential of Cannabis and Its Constituent Cannabinoids Research Supported by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) -- Conducting Research with Schedule I Substances -- Obtaining and Modifying a Registration to Conduct Research with Cannabis and Other Schedule I Drugs is Challenging -- NIDA Is the Only Source of Cannabis in the United States Permitted for Research -- Researchers Are Unable to Access Marketed Cannabis Products -- Statement of Douglas C. Throckmorton, M.D. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration Prepared Statement of Douglas C. Throckmorton -- Introduction -- Statement of Matthew J. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration -- Prepared Statement of the U.S. Department of Justice, Matthew J. Strait -- The Controlled Substances Act and Marijuana -- Current Statutory Framework Governing the Registration of Certain Individuals Handling Marijuana under the CSA -- DEA's August 2016 Policy Statement and Subsequent Efforts to Expand the Number of Registrants to Grow Marijuana -- Conclusion -- Prepared Statement of Hon. Eliot L. Engel 116th Congress, 1st Session, H.R. 171 -- A BILL -- Section 1. Short Title -- Sec. 2. Scheduling of Marijuana -- Prescriptions -- Sec. 3. Definitions -- Sec. 4. Relation of Act to Certain Prohibitions Relating to Smoking -- 116th Congress, 1st Session, H. R. 601 -- A BILL -- Section 1. Short Title -- Sec. 2. Increasing the Number of Federally Registered Manufacturers of Cannabis for Legitimate Research Purposes -- Sec. 3. Provision by Department of Veterans Affairs Health Care Providers of Information Regarding Veteran Participation in Federally Approved Cannabis Clinical Trials Marijuana Government policy United States. Marijuana Politique gouvernementale États-Unis. Marijuana Government policy fast |
| title | New Policies on Marijuana's Status. |
| title_auth | New Policies on Marijuana's Status. |
| title_exact_search | New Policies on Marijuana's Status. |
| title_full | New Policies on Marijuana's Status. |
| title_fullStr | New Policies on Marijuana's Status. |
| title_full_unstemmed | New Policies on Marijuana's Status. |
| title_short | New Policies on Marijuana's Status. |
| title_sort | new policies on marijuana s status |
| topic | Marijuana Government policy United States. Marijuana Politique gouvernementale États-Unis. Marijuana Government policy fast |
| topic_facet | Marijuana Government policy United States. Marijuana Politique gouvernementale États-Unis. Marijuana Government policy United States |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3641863 |
| work_keys_str_mv | AT leejackm newpoliciesonmarijuanasstatus |